By:
On:
In: Neurological, Obesity, Pain and Pain Management

FRIDAY, Sept. 16, 2022 (HealthDay News) — Bariatric surgery aims to help severely obese patients shed significant weight, and now new research shows that many can also look forward to lasting pain relief and mobility. Though many patients regain some weight in the first couple of years after bariatric surgery,Continue Reading

By:
On:
In: Fitness & Exercise, Kids' Health, Neurological

FRIDAY, Sept. 16, 2022 (HealthDay News) — While adults typically need steroid medication to treat Bell’s palsy, most children can recover without treatment, a new study finds. Bell’s palsy temporarily causes weakness and paralysis in facial muscles, making half of the face droop. The study — a randomized controlled trialContinue Reading

By:
On:
In: Head & Neck, Kids' Health, Neurological, Public Health

WEDNESDAY, Sept. 14, 2022 (HealthDay News) — Efforts to prevent concussions from happening at school or school-related sports activities may help keep teens from lagging behind on their academics. In a new study, researchers at the University of Washington found that those who had a recent concussion could be 25%Continue Reading

By:
On:
In: Arthritis, Bones & Joints, Infectious Disease, Neurological, Sexual Health

MONDAY, Sept. 12, 2022 (HealthDay News) — Though the risk appears small, a new review suggests that, in rare instances, monkeypox may trigger serious neurological complications, including seizures and brain inflammation. The finding is based on a look at 19 studies conducted in the United States, the United Kingdom andContinue Reading

By:
On:
In: Health & Technology, Kids' Health, Neurological, Women's Health

MONDAY, Sept. 12, 2022 (HealthDay News) — A frequently used screening test for autism creates a gender gap that could hinder diagnosis and treatment for women and girls, a new study suggests. Researchers who study autism have been working to include more women and girls in their studies in recentContinue Reading

By:
On:
In: Diseases, Neurological

THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for ALS (amyotrophic lateral sclerosis). The FDA is not obligated to follow its advisors’ recommendations, though it usually does. Wednesday’s vote was 7-2Continue Reading

By:
On:
In: Diseases, Genetics and Genetic Disorders, Health & Technology, Neurological

WEDNESDAY, Sept. 7, 2022 (HealthDay News) — Patients suspected of having amyotrophic lateral sclerosis (ALS) may soon be able to get a diagnosis much more quickly, not wasting the precious time many have left, new research suggests. In 2020, a blood test for ALS based on microRNA (short segments ofContinue Reading

By:
On:
In: Mental Health, Neurological, Vitamins / Drugs

TUESDAY, Sept. 6, 2022 (HealthDay Now) — For Mary Christ, the idea that depression is a chemical imbalance in the brain has always felt true to her personal experience. A former educator, Christ, 57, has taken antidepressants for much of her adult life. She experienced bouts of anxiety and panicContinue Reading

By:
On:
In: Hormones and Disease, Mental Health, Neurological, Special Needs

THURSDAY, Sept. 1, 2022 (HealthDay News) — Men with Down syndrome may think and remember better when treated with a brain hormone normally associated with fertility, a new small-scale study suggests. Rhythmic drip doses of gonadotropin-releasing hormone (GnRH) improved thinking skills in nearly all of a small group of adultContinue Reading